Terry Minton, Chairman and CEO — Mr. Minton has more than 25 years of senior executive experience in both large organizations and entrepreneurial enterprises. His passion for people, leadership, and business has served him well in leading healthcare service enterprises, a biotechnology company, and new technology initiatives including product companies, both B2B and B2C.

John Littleton, MD, PhD — Chief Scientific Officer & Co-Founder — Dr. Littleton has invested 30 years in pharmacological research and development related to drug discovery, including close collaboration with industry both in Europe and the USA. The last 12 years have focused on novel ways of discovering natural products including co-invention of the platform technology used by Naprogenix, and 8 years as CSO of Naprogenix.

Deane Falcone, PhD — Chief Molecular Scientific Officer & Co-Founder — Dr. Falcone has over 25 years experience in research and development in the field of plant biology. He is a co-founder of Naprogenix as well as a co-inventor of the platform technology used by Naprogenix. He has served as CMSO for Naprogenix for the past 8 years.

Cindy Burklow, MBA, MS — Chief Operating Officer — Ms. Burklow has over 14 years of executive experience and has led technology startups with international supply chains for both B2B and B2C sales. She has served as COO for Naprogenix for the past 7 years.

David McClure, PhD, JD, RAC — VP for Product Development/IP — Dr. McClure has provided product development and intellectual property expertise to dozens of pharma and biotech companies.